Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16044965rdf:typepubmed:Citationlld:pubmed
pubmed-article:16044965lifeskim:mentionsumls-concept:C0699791lld:lifeskim
pubmed-article:16044965lifeskim:mentionsumls-concept:C0029298lld:lifeskim
pubmed-article:16044965lifeskim:mentionsumls-concept:C0014441lld:lifeskim
pubmed-article:16044965pubmed:issue7lld:pubmed
pubmed-article:16044965pubmed:dateCreated2005-7-27lld:pubmed
pubmed-article:16044965pubmed:abstractTextA number of enzymes have been shown to be involved in the process of activation and/or degradation of 5-fluorouracil, and they are potential candidates for predicting factors of chemosensitivity to 5-fluorouracil. Among them, orotate phosphoribosyltransferase (OPRT EC 2.4.2.10) is a key enzyme related to the first-step activation process of 5-fluorouracil and therefore it has been shown to be an important enzyme for the prediction of sensitivity to 5-fluorouracil and its related derivatives. We developed a new enzyme-linked immunosorbent assay (ELISA) system to accurately assess intratumoral activity of orotate phosphoribosyltransferase. A new sandwich ELISA system was established using anti-OPRT polyclonal antibodies obtained from the rabbit immunized with the recombinant human peptides of the OPRT molecule. OPRT levels were measured in 8 human cancer xenografts transplanted in nude mice and 58 gastric cancer tissues using both a newly established ELISA and a conventional enzyme assay using radiolabeled 5-fluorouracil as a substrate. OPRT levels in 8 human cancer xenografts measured by this ELISA were significantly correlated with the OPRT enzyme activities (r2=0.782). Furthermore, OPRT activities measured in 58 gastric cancer tissues by enzyme assay were significantly correlated with those measured by the newly-established ELISA (r2=0.664). The ELISA system developed for the measurement of OPRT required a minimal amount of carcinoma tissue samples, which could be an easy-of-use assay system to predict sensitivity to 5-fluorouracil in gastric carcinoma. These results suggest that this newly-developed sandwich ELISA system for the quantification of OPRT is technically simple, feasible, and may be a useful tool to predict sensitivity to fluoropyrimidine-based anticancer chemotherapy in patients with gastric carcinoma and other cancers.lld:pubmed
pubmed-article:16044965pubmed:languagejpnlld:pubmed
pubmed-article:16044965pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16044965pubmed:citationSubsetIMlld:pubmed
pubmed-article:16044965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16044965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16044965pubmed:statusMEDLINElld:pubmed
pubmed-article:16044965pubmed:monthJullld:pubmed
pubmed-article:16044965pubmed:issn0385-0684lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:FukushimaMasa...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:SugimotoYoshi...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:TanakaHideyuk...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:NakamuraYasuk...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:SakuraiYoichi...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:OchiaiMasahir...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:UyamaIchiroIlld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:KomoriYoshiyu...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:MasuiToshihik...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:SakamotoKazuk...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:YoshidaIkuoIlld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:TonomuraShuhe...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:ShojiMitsutak...lld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:OkaToshinoriTlld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:InabaKazukiKlld:pubmed
pubmed-article:16044965pubmed:authorpubmed-author:MatsuuraShiro...lld:pubmed
pubmed-article:16044965pubmed:issnTypePrintlld:pubmed
pubmed-article:16044965pubmed:volume32lld:pubmed
pubmed-article:16044965pubmed:ownerNLMlld:pubmed
pubmed-article:16044965pubmed:authorsCompleteYlld:pubmed
pubmed-article:16044965pubmed:pagination1017-22lld:pubmed
pubmed-article:16044965pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:meshHeadingpubmed-meshheading:16044965...lld:pubmed
pubmed-article:16044965pubmed:year2005lld:pubmed
pubmed-article:16044965pubmed:articleTitle[Establishment of enzyme-linked immunosorbent assay for quantification of orotate phosphoribosyltransferase in gastric carcinoma].lld:pubmed
pubmed-article:16044965pubmed:affiliationDept. of Surgery, Fujita Health University School of Medicine.lld:pubmed
pubmed-article:16044965pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16044965pubmed:publicationTypeEnglish Abstractlld:pubmed